Approval · Notice of Compliance 35325 · 2025
ANDROCUR: Notice of Compliance 35325
Issued May 8, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35325
- Date
- May 8, 2025
- Company
- Amdipharm LimitedNorthwood, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROCUR | 00704431 | Marketed |
| ANDROCUR DEPOT | 00704423 | Cancelled Post Market |
Medicinal ingredients
- CYPROTERONE ACETATE 50 MG per TAB
- CYPROTERONE ACETATE 100 MG per ML